Cargando…
Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy
INTRODUCTION: Mismatch repair immunohistochemistry (MMR IHC) or microsatellite instability (MSI) testing is now routinely performed in patients with colorectal cancer (CRC) to select those requiring Lynch syndrome testing. MMR IHC is also carried out on CRC and upper gastrointestinal (GI) cancers to...
Autores principales: | R., Openshaw M., J., Williams, T., Foo, C., Moss, A., Wotherspoon, N., Starling., Z., Kemp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415243/ https://www.ncbi.nlm.nih.gov/pubmed/36018445 http://dx.doi.org/10.1007/s12029-022-00859-3 |
Ejemplares similares
-
Screening of Lynch syndrome in endometrial cancer in Iranian population with mismatch repair protein by immunohistochemistry
por: Noei Teymoordash, Somayyeh, et al.
Publicado: (2022) -
Frequent mismatch-repair defects link prostate cancer to Lynch syndrome
por: Dominguez-Valentin, Mev, et al.
Publicado: (2016) -
Prevalence of Lynch syndrome in women with mismatch repair‐deficient ovarian cancer
por: Hodan, Rachel, et al.
Publicado: (2020) -
Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors
por: Kim, Hyunhee, et al.
Publicado: (2021) -
Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
por: Rasmussen, Maria, et al.
Publicado: (2023)